Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Sales | 398 | 226 | 30,301 | 215 | 25,154 |
| Gross Profit | 398 | 226 | 30,301 | 215 | 25,154 |
| Operating Expenses | 14,551 | 12,452 | 13,265 | 9,765 | 8,435 |
| Operating Income | -14,153 | -12,226 | 17,036 | -9,550 | 16,719 |
| Other Income | 102 | 78 | -116 | -1 | -112 |
| Pre-tax Income | -14,051 | -12,148 | 16,920 | -9,551 | 16,607 |
| Income Tax | N/A | 54 | 7,189 | 6 | 178 |
| Net Income Continuous | -14,051 | -12,202 | 9,731 | -9,557 | 16,429 |
| Net Income | $-14,051 | $-12,202 | $9,731 | $-9,557 | $16,429 |
| EPS Basic Total Ops | -0.78 | -0.69 | 0.79 | -0.57 | 1.05 |
| EPS Basic Continuous Ops | -0.78 | -0.69 | 0.88 | -0.57 | 1.05 |
| EPS Diluted Total Ops | -0.78 | -0.69 | 0.89 | -0.57 | 0.88 |
| EPS Diluted Continuous Ops | -0.78 | -0.69 | 0.95 | -0.57 | 0.88 |
| EBITDA(a) | $-13,652 | $-11,962 | $15,731 | $-9,508 | $16,754 |